A 28-year-old nulliparous woman presents to the family planning clinic requesting long-acting reversible contraception. She has a regular 28-day menstrual cycle with moderate dysmenorrhea and heavy menstrual bleeding (soaking 8–10 pads per day). She has no history of pelvic inflammatory disease, ectopic pregnancy, or sexually transmitted infections. On examination, her uterus is normal size with no adnexal masses. She is keen to avoid hormonal methods due to concerns about weight gain. Which IUCD would be most appropriate for this patient?

Explanation

## Clinical Scenario Analysis This patient has **heavy menstrual bleeding and dysmenorrhea** — the key clinical drivers of the answer. While she is nulliparous (which does not contraindicate IUCD insertion in modern practice), her menstrual pathology makes the choice clear. ## Why LNG-IUS is Correct **Key Point:** The levonorgestrel-releasing IUCD (LNG-IUS, e.g. Mirena) is the **gold standard IUCD for women with heavy menstrual bleeding and dysmenorrhea** because: 1. **Reduces menstrual blood loss by 60–90%** — achieved through local endometrial suppression and reduced prostaglandin synthesis 2. **Alleviates dysmenorrhea** — due to both reduced flow and direct anti-inflammatory effects 3. **Maintains systemic contraceptive efficacy** — Pearl Index ~0.2 (comparable to copper devices) 4. **Provides additional benefits**: reduced ovarian cyst formation, improved bone density in some studies, and can be used off-label for menorrhagia management **Clinical Pearl:** The LNG-IUS is particularly valuable in nulliparous women with heavy periods because it addresses both contraceptive and therapeutic needs in a single intervention — avoiding the need for separate hormonal therapy or NSAIDs. ## Why Copper T 380A Is Suboptimal Here While copper devices are excellent first-line contraceptives and **do NOT worsen menstrual bleeding** in most women, they: - **May increase menstrual blood loss by 20–30%** in susceptible users - **Do not relieve dysmenorrhea** — may even exacerbate it in some cases - Would be contraindicated or poorly tolerated in this patient given her existing heavy bleeding and pain **High-Yield:** Copper IUCDs are ideal for women with **normal or light menses** and no dysmenorrhea; LNG-IUS is ideal for women with **heavy menses and/or dysmenorrhea**. ## Comparison Table | Feature | Copper T 380A | LNG-IUS (Mirena) | | --- | --- | --- | | **Menstrual blood loss** | May increase 20–30% | Reduces 60–90% | | **Dysmenorrhea** | No improvement; may worsen | Marked improvement | | **Contraceptive efficacy** | Pearl Index 0.6–0.8 | Pearl Index 0.2 | | **Duration** | 10 years | 5 years (some formulations 7 years) | | **Hormone-free** | Yes | No (local levonorgestrel) | | **Nulliparity** | Not contraindicated | Not contraindicated | | **Best for** | Normal/light menses | Heavy menses, dysmenorrhea | ## Nulliparity Clarification **Key Point:** Modern guidelines (WHO, ACOG, FIGO) **do NOT contraindicate IUCD insertion in nulliparous women** — the old myth of "save IUCDs for multiparous women" is outdated. Both copper and LNG-IUS are safe and effective in nulliparous users, with comparable expulsion and perforation rates to parous women when inserted by trained providers. ## Why Other Options Are Wrong - **Copper 7**: Older device with lower efficacy (Pearl Index ~2.0) and higher expulsion rates; rarely used today. - **Progesterone-releasing IUCD**: Provides only 1 year of contraception and requires annual replacement; not suitable for long-term contraception in this case.